Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-Naïve and CYP17 Inhibitor-Naïve Patients: Follow-Up From the ARADES and ARAFOR Trials

European Urology Focus - Netherlands
doi 10.1016/j.euf.2017.01.015
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Elsevier BV


Related search